FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pertti Pentikäinen

Research Profile

Chemicals & Drugs

Procedures

Disorders

Phenomena

Concepts & Ideas

Anatomy

Respiratory System

Co-author Network

Publications

TOP 3
Jaakko Puttonen; Tarmo Laine; Meri Ramela; Sari Häkkinen; Wenhui Zhang; Rajendra Pradhan; Pertti J Pentikäinen; Mikko Koskinen
Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.
Jaakko Puttonen; Sampo Kantele; Matti Kivikko; Sari Häkkinen; Veli-Pekka Harjola; Petri Koskinen; Pertti J Pentikäinen
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
Saila Antila; Matti Kivikko; Lasse Lehtonen; Jaan Eha; Aira Heikkilä; Pasi Pohjanjousi; Pertti J Pentikäinen
Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pertti Pentikäinen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jaakko Puttonen; Tarmo Laine; Meri Ramela; Sari Häkkinen; Wenhui Zhang; Rajendra Pradhan; Pertti J Pentikäinen; Mikko Koskinen
Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;32(4-5):271-7.
2007: Jaakko Puttonen; Sampo Kantele; Matti Kivikko; Sari Häkkinen; Veli-Pekka Harjola; Petri Koskinen; Pertti J Pentikäinen
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
Clinical pharmacokinetics 2007;46(3):235-46.
2004: Saila Antila; Matti Kivikko; Lasse Lehtonen; Jaan Eha; Aira Heikkilä; Pasi Pohjanjousi; Pertti J Pentikäinen
Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan.
British journal of clinical pharmacology 2004;57(4):412-5.
2004: Lasse Lehtonen; Saila Antila; Pertti J Pentikäinen
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
Clinical pharmacokinetics 2004;43(3):187-203.
2002: Matti Kivikko; Saila Antila; Jaan Eha; Lasse Lehtonen; Pertti J Pentikäinen
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure.
International journal of clinical pharmacology and therapeutics 2002;40(10):465-71.
2002: Lasse Lehtonen; Pertti J Pentikäinen
[Are there differences between beta blocking agents?].
Duodecim; lääketieteellinen aikakauskirja 2002;118(12):1273-81.
2002: Matti Kivikko; Saila Antila; Jaan Eha; Lasse Lehtonen; Pertti J Pentikäinen
Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.
Journal of clinical pharmacology 2002;42(1):43-51.
2001: H Heikkinen; M Saraheimo; Saila Antila; P Ottoila; Pertti J Pentikäinen
Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
European journal of clinical pharmacology 2001;56(11):821-6.